Highly absorbable and scientifically proven effective
Three drugs are FDA-approved to treat Alzheimer's: Aducanumab-avwa (Aduhelm), lecanemab-irmb (Leqembi), and donanemab-azbt (Kisunla)
Several competitors are pursuing similar or alternative approaches, and the competitive landscape could influence pricing, availability, and insurance coverage
Systematic screening of potential beta-cell imaging agents
The Effects of Medium-Chain Triglyceride Oil Supplementation on Endurance Performance and Substrate Utilization in Healthy Populations: A Systematic Review
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, et al